Excelerate Raised Its Dividend Again-But at 0.8%, Is the Stock Already Fairly Priced?

Excelerate's dividend hike confirms strength, but the yield limits the income case

The key signal is simple: Excelerate lifted its quarterly payout to $0.09 per share, but the stock still yields only about 0.84%. That combination suggests this is not an income stock in the usual sense. With a yield under 1%, investors are not getting paid much to wait; they are betting the business can keep growing cash flows enough for the stock to do the heavy lifting.

Excelerate also has a more flexible asset base than many midstream names. It owns and operates floating regasification terminals and related terminal services, allowing it to add regasification capacity where customers need it most. That flexibility can be valuable in markets looking for faster LNG import solutions.

The real question, then, is not yield but valuation. Bulls can point to $449.3 million of 2025 adjusted EBITDA and $122.2 million of Q1 2026 adjusted EBITDA as evidence that the business is generating real operating strength. Bears will counter that once those numbers are known, much of the good news may already be in the stock. My view: the dividend increase is a constructive signal, but at this yield Excelerate looks more fairly valued than obviously cheap.

The dividend increase matters because it points to current cash generation

A higher payout matters because it suggests Excelerate is generating enough cash to do more than talk about growth. The next question is whether that cash keeps showing up after the business funds the upkeep its fleet needs. One strong quarter is encouraging; repeated quarterly follow-through is what matters.

What investors need to verify next

The dividend hike alone does not prove the cash stream will keep stretching. Investors should watch how management allocates capital: - how much cash remains available after asset upkeep, - how much goes to projects that are already contracted, and - whether new spending is earning an attractive return.

That keeps the focus on sustainability, not a one-quarter headline.

Why the Jordan deal matters

Jordan is a useful example of the kind of demand investors want to see. Excelerate executed a definitive nine-month time charter party agreement to deploy Excelerate Acadia to Aqaba. Management has also referenced a five-year regasification services agreement tied to that deployment.

A nine-month charter is not the same thing as a long-duration contract, but it still matters. It shows active demand and gives Excelerate another revenue stream while other projects remain in motion. For investors, the key is whether shorter deployments keep feeding into longer, more predictable cash flows.

Valuation is the real debate: durable cash flows, or a story the market already understands?

The bigger question is no longer whether Excelerate can generate cash. It is whether a company producing that kind of cash is already being valued like a quality name rather than sold as a bargain. With the stock carrying a market cap of $4.35 billion and a 0.84% dividend yield, the market is clearly paying for more than just the latest payout increase to $0.09 per share.

Why the bullish case still exists

Bulls are not buying EE for the income. They are buying it for contract durability. Bangladesh is now receiving LNG cargo deliveries under previously announced 15-year LNG Sale and Purchase agreements. That is the kind of long-dated structure that can make the business look more like predictable infrastructure and less like a cyclical operating story.

Jordan adds another layer to that case. Excelerate secured a definitive nine-month time charter party agreement to send Excelerate Acadia to Aqaba, and management is also describing a five-year regasification services agreement. Short-term wins can be profitable, but longer contracts are what help investors underwrite future cash flows with more confidence.

Why some of the good news may already be priced in

Bears will focus on the financing needed to support that growth. Excelerate has term loan facilities and notes, so debt service and refinancing risk matter. If project timing slips or financing costs rise, there is less left over for shareholders.

Timing risk is not hypothetical. Management said it is revising full-year guidance to reflect the delayed startup of our Iraq terminal. That pushes more near-term reliance onto existing contracts and currently active deployments.

What would clarify the valuation debate

• Market is right: dividends keep rising, but the stock remains range-bound because debt, interest costs, or further project delays limit upside.
• Market is wrong: Bangladesh, Jordan, and additional long-duration wins convert into steadily higher cash flows fast enough to support a stronger valuation.
• Neutral watchpoint: new contract extensions and minimum-offtake language need to keep appearing, ideally before investors start pricing Iraq back into the story.

What would improve the setup from here?

Signals that would strengthen the case

• Another dividend increase. The board already lifted the payout to $0.09 per share and cited a low double-digit annual dividend growth rate through 2028. Another raise would show the latest increase was not a one-quarter event.
• More long-duration contract language. Bangladesh is already tied to 15-year LNG Sale and Purchase agreements, and Jordan came with a five-year regasification services agreement referenced by management. More structure like that would make future cash flows easier to underwrite.
• Another steady operating quarter. Excelerate just reported $122.2 million of Q1 2026 adjusted EBITDA. Holding near that level would suggest execution remains on track.

Position sizing matters at a 0.84% yield

With a 0.84% dividend yield, EE is better viewed as a growth-oriented position than a core income holding. That matters for sizing: the stock may deserve ownership if follow-through continues, but not so much size that one delay materially damages portfolio performance.

What would weaken the thesis

Watch the financing structure: term loan facilities and notes. If debt pressure rises at the same time delays push more weight onto existing projects, the equity case becomes harder to defend.

Verdict: constructive, but not compelling on the dividend hike alone. The stock looks better supported than the yield suggests, yet still more fairly valued than obviously undervalued until follow-through confirms the story.